Khmelnytskyi Regional Hospital

Khmelnytskyi 29007

0 studies enrolling now · 4 studies all time

What they study most

Acute Myeloid Leukemia, Myocardial Infarction, Part 1：r/r B-cell Malignancies, Part 2：B-cell Malignancies, cUTI

Studies at this site

• A Study of Tyrosine Kinase Inhibitor Orelabrutinib (ICP-022) in Patients With r/r B-Cell Malignancies — Running, not enrolling
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia — Completed
• Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections — Completed